AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02157974 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Byetta 5Mcg Pen Injection
Description: 10 participants will receive 2 doses of Byetta, one at 7 PM the night prior to metabolic study and the second 30 min before ingestion of glucola
Study NCT03781622 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: WOLF Thrombectomy Device
Description: Mechanical thrombectomy for the neurovasculature
Study NCT00679081 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CelTx
Description: Single application; split-mouth design
Study NCT00679081 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Autologous sub-epithelial connective tissue graft
Description: Single application; split-mouth design
Study NCT03643250 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Smaller Portion Size and Standard Appeal (non-divided plate)
Description: Food with Smaller Portion Size and Standard Appeal on a non-divided plate
Study NCT03643250 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Smaller Portion Size and Enhanced Appeal (divided plate)
Description: Food with Smaller Portion Size and Enhanced Appeal on a divided plate
Study NCT03643250 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Larger Portion Size and Standard Appeal (non-divided plate)
Description: Food with Larger Portion Size and Standard Appeal on a non-divided plate
Study NCT03643250 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Larger Portion Size and Enhanced Appeal (divided plate)
Description: Food with Larger Portion Size and Enhanced Appeal on a divided plate
Study NCT03643250 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Smaller Portion Size and Standard Appeal (divided plate)
Description: Food with Smaller Portion Size and Standard Appeal on a divided plate
Study NCT04303221 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: The exercises will be performed three times a week (Mondays, Wednesdays and Fridays), lasting 60 min, 10 minutes of warm-up, 40 min of multisensory exercises, and 10 min of final relaxation, for 12 weeks.
Study NCT00545428 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Rhinoplasty
Description: Mastoid bone autograft for dorsal nasal augmentation
Study NCT04855279 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: neutral sodium fluoride
Description: Topically applied
Study NCT04855279 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: ACP-CCP gel
Description: Topically applied
Study NCT04855279 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: nano-hydroxyapatite solution
Description: Topically applied
Study NCT04855279 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: glycerine
Description: Topically applied
Study NCT01724515 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Lipid infusion and muscle biopsies
Description: Subjects will undergo a baseline muscle biopsy, a lipid infusion for 5 hours (60 ml/hr), and a muscle biopsy after the lipid infusion.
Study NCT03904381 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 5-fluorouracil
Description: 5-fluorouracil subconjunctival injections were a first-choice therapy for bleb failure and were administered according to predetermined criteria.
Study NCT03904381 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Transconjunctival needling
Description: Transconjunctival needling was administered according to predetermined criteria.
Study NCT03904381 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Transconjunctival revision
Description: Transconjunctival revision was administered according to predetermined criteria.
Study NCT01745679 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ceftriaxone treatment
Description: ceftriaxone will be administered à high dose : > or equal to 75mg/kg/day or 4 gr/day
Study NCT03022643 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Interpersonal Social Rhythms Psychotherapy
Description: The treatment involves 8-weeks of individual psychotherapy. Weekly sessions will be 60-minute long and will take place at the Pain Research Center. The treatment focuses on 1) the link between life events, pain severity, sleep disturbances, fatigue, and mood, 2) social and behavioral rhythms and sleep-wake disturbances, 3) identification and management of rhythm dysregulation and the triggers for it, 4) allowing and facilitating the mourning of the loss healthy self, 5) identification and appropriate management of symptoms.
Study NCT03022643 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Bright Light Device
Description: All patients will be provided with a bright light device (Re-Timer) and will be instructed to use it in the first 2-hours of the day (for a minimum of 30 minutes) throughout the 8-week treatment period.
Study NCT00957021 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Triathlon® PS Total Knee System
Description: Triathlon® PS Total Knee system
Study NCT01462708 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [18F]MK-9470
Description: Subjects will be injected with 10 mCi, and not to exceed 11 mCi (not >10% of 10 mCi limit)of \[18F\]MK-9470, followed by PET imaging.
Study NCT02376881 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Erythropoietin
Description: 20,000 IU epo IV infusion in 100 ml normal saline in 2 hr for 3 successive days
Study NCT02376881 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: 100 ml normal saline in 2 hr for 3 successive days
Study NCT01804244 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TMC278
Description: 1 25-mg tablet \[27.5 mg as the hydrochloride salt) taken orally (by mouth) within 10 minutes after completion of a standardized breakfast on Day 1.
Study NCT00620893 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: PEG- 400 based artificial tear
Description: Baseline: Instill one drop in the randomized eye four times daily starting the day after surgery can be used more frequently if needed Month 3: Instill one drop in the randomized eye twice daily
Study NCT00620893 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Systane
Description: Baseline: Instill one drop in the randomized eye four times daily starting the day after surgery can be used more frequently if needed Month 3: Instill one drop in the randomized eye twice daily
Study NCT00262392 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pamidronate (AREDIA)
Description: Pamidronate (AREDIA) vs radiation
Study NCT00262392 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pamidronate (AREDIA)
Description: Pamidronate (AREDIA) vs radiation
Study NCT03089515 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Cardio-Pulmonary Exercise Testing (CPET)
Description: This test helps determine if the decreased tolerance to exercise or shortness of breath with activity a patient is experiencing is caused by a cardiac disease, versus a pulmonary disease.
Study NCT03089515 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cardio-Pulmonary Exercise Testing (CPET)
Description: This test helps determine if the decreased tolerance to exercise or shortness of breath with activity a patient is experiencing is caused by a cardiac disease, versus a pulmonary disease.
Study NCT00354835 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cyclophosphamide
Description: Given IV
Study NCT03650608 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cohort 2: HL217 Ophathalmic Solution BID
Description: Cohort 2 (Twice a day)
Study NCT04327648 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Social interaction treatment
Description: Children in social interaction treatment group will have 30min social interaction each day for 3 months.
Study NCT04327648 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Neuronal cognition treatment
Description: Children in neuronal cognition treatment group will experienced neural cognition training 30min each day for 3 months.
Study NCT00354835 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Given IV
Study NCT03650608 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cohort 3: HL217 Ophthalmic Solution QID
Description: Cohort 3 (Four times a day)
Study NCT03650608 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Ophthalmic solution
Description: Placebo
Study NCT04327648 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Routine treatment
Description: Children in routine treatment group will keep the same initial treatment.
Study NCT01573793 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Parenting Education
Description: Will receive parenting educational materials hypothesized to enhance emotional and cognitive development
Study NCT01573793 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Control Group - Safety Materials
Description: Will receive safety and dental hygiene materials that have no bearing on emotional and cognitive development
Study NCT03019588 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: IV infusion
Study NCT03019588 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Paclitaxel
Description: IV infusion
Study NCT00354835 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Dactinomycin
Description: Given IV
Study NCT02269605 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Group 1: Placebo (sodium chloride 0.8 %) at single dose
Study NCT02269605 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bryostatin 1 (10ug/m2)
Description: Group 2: Bryostatin 1 (10ug/m2) at single dose
Study NCT02269605 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bryostatin 1 (20ug/m2)
Description: Group 3: Bryostatin 1 (20ug/m2) at single dose
Study NCT02958527 — intervention group
Intervention type: DRUG
Intervention: venlafaxine
Description: The usual adult starting dosage for oral use is 37.5 mg of venlafaxine once daily, which is increased to 75 mg once daily after a meal from 1 week later. The dose may be adjusted within a range not exceeding 225 mg/day according to the patient's age and symptoms. However, the dose should be increased by 75 mg/day at intervals of not less than 1 week.
Study NCT00142597 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Acupuncture
Description: Involves the insertion and manual stimulation of thin acupuncture needles into specific points in the body.~Fibromyalgia participants will be randomized to receive 9 acupuncture treatments over the course of four weeks.~All participants will be scanned twice using the fMRI scanner. The PET portion of the study is optional.
Study NCT00142597 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham treatment
Description: Fibromyalgia participants will be randomized to receive 9 sham treatments over the course of four weeks.~All participants will be scanned twice using the fMRI scanner. The PET portion of the study is optional.
Study NCT03033212 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Therapist-Guided Rehabilitation
Description: Rehabilitation consists of exercises guided by a certified physical therapist. These exercises include: aerobics, walking tests, stability exercises, and strengthening exercises.
Study NCT03033212 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Self-Guided Rehabilitation
Description: Rehabilitation consists of self-guided exercises with provided instructions. These exercises include: aerobics, walking tests, stability exercises, and strengthening exercises.
Study NCT03472677 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ice Pack and Cooling Device
Description: A comparison of two cooling methodologies in healthy volunteers after single intra-articular (IA) injection (15 mL) of 2% lidocaine (without epinephrine).
Study NCT03472677 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CNTX-4975-05 (trans-capsaicin)
Description: Controlled cooling wrap vs ice pack cooling after single IA injection of 1 mg CNTX-4975-05 in each arm after single IA (15 mL) injection of 2% lidocaine (without epinephrine).
Study NCT03472677 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CNTX-4975-05 (trans-capsaicin)
Description: Controlled cooling parameters will be determined after evaluation of data from prior Cohort(s) after single IA injection (15 mL) of 2% lidocaine (without epinephrine) and single IA injection of 1 mg CNTX-4975-05.
Study NCT03472677 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CNTX-4975-05 (trans-capsaicin)
Description: Controlled cooling with knee device vs no cooling (determined after evaluation of data from previous cohorts) after single IA injection (15 mL) of 2% lidocaine (without epinephrine) and single IA injection of 1 mg CNTX-4975-05.
Study NCT03472677 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capsaicin
Description: Four intradermal injections of capsaicin, two on each forearm.
Study NCT01356485 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MP4CO
Description: 43 mg/mL pegylated carboxyhemoglobin \[≥ 90% CO hemoglobin saturation\] in physiological acetate electrolyte solution
Study NCT01356485 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Sodium chloride solution
Description: Normal saline (0.9% sodium chloride solution)
Study NCT00922051 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Study NCT00922051 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Description: Placebo
Study NCT01938937 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial bright light device
Study NCT01938937 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Transcranial sham device
Study NCT04351971 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intervention Group
Description: The patient's position is in the supine position. The therapist identifies the arches of the atlas and positions one hand at this level with the fingers extended. The other hand is located in the occipital region. Subsequently, the therapist makes a pressure with his shoulder assessing the movement and applies a pressure to the back. This technique is performed by mobilization cycles of 15 seconds and 3 seconds of rest for a total period of 5 minutes.The patient's position is in the supine position. The therapist identifies the arches of the atlas and positions one hand at this level with the fingers extended. The other hand is located in the occipital region. Subsequently, the therapist makes a pressure with his shoulder assessing the movement and applies a pressure to the back. This technique is performed by mobilization cycles of 15 seconds and 3 seconds of rest for a total period of 5 minutes.
Study NCT04351971 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Placebo group
Description: The technique consists of placing the patient in the supine position, one hand is located in the arches of the atlas, the other hand is located in the occipital. The therapist's shoulder is located in the anterior region. This position is maintained for 5 minutes without exerting pressure.
Study NCT01309191 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Minoxidil
Description: Over the counter Rogaine, twice a day for 8 weeks
Study NCT01309191 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT01993758 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Low tourniquet pressure
Description: Tourniquet pressure set as 120mmHg above the systolic blood pressure just before tourniquet inflation
Study NCT01993758 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional tourniquet pressure
Description: Tourniquet pressure set as 150mmHg above the systolic blood pressure just before tourniquet inflation
Study NCT02466581 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sulphasalazine + Hydroxychloroquine OR Prednisolone
Description: Methotrexate: 25mg/week. SSZ: 2 g/day. HCQ: 35 mg/kg/week (Finland and Denmark) Methotrexate: 25mg/week. Prednisolone 20 mg/day tapered in 9 weeks to 5 mg/day, discontinued after 9 months. (Sweden, Norway, and Iceland)
Study NCT03942614 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nordic pole walking
Study NCT03304951 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sinopsys® Lacrimal Stent
Description: The Sinopsys® Lacrimal Stent is indicated for use in creating a transcaruncular ethmoid access.
Study NCT02466581 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Cimzia
Description: Certolizumab-pegol: 200 mg s.c. every other week. Methotrexate: 25mg/week
Study NCT00354835 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Dactinomycin
Description: Given IV
Study NCT00354835 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Irinotecan Hydrochloride
Description: Given IV
Study NCT00354835 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study NCT00354835 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study NCT00354835 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT00354835 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT00354835 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Radiation Therapy
Description: Undergo radiotherapy
Study NCT00354835 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation Therapy
Description: Undergo radiotherapy
Study NCT00354835 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vincristine Sulfate
Description: Given IV
Study NCT00354835 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vincristine Sulfate
Description: Given IV
Study NCT00636545 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oblimersen (Genasense)
Description: Intravenous
Study NCT03581097 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Video Group
Description: Patients in the film group watched the film using a laptop computer equipped with headphones, and Visual Analog Pain Scale (VAS) was repeated after the movie. Video was recorded by the Anaesthesiology department team, in order to explain and show in a detailed way on a model, the sequence of events, which occurs between the arrival of patients in the operating room and the performance of Intra-Venous Regional Anesthesia (IVRA)
Study NCT03049748 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Mobile phone app (VAD Care App)
Description: VAD Care App is a novel self-management tool being tested for patients with implantable LVADs. The app has daily push notifications (alerts), cues for daily self-management tasks, two-way communication using text messages and videoconferencing (virtual clinic), and links to LVAD self-management skills and videos easily accessible for self-management skill review.
Study NCT03049748 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual LVAD Care
Description: Routine clinic follow-up visits over 6 months. Patients and caregivers will both receive self-management education post discharge and as needed throughout the duration of the study.
Study NCT03049748 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Usual LVAD Care
Description: Routine clinic follow-up visits over 6 months. Patients and caregivers will both receive self-management education post discharge and as needed throughout the duration of the study.
Study NCT01882686 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Classification Based Cognitive Functional Therapy
Description: A novel multidimensional classification system has been developed incorporating the biopsychosocial model, which subgroups patients based on their presentation. This subclassification is the base for matched interventions directed at the maladaptive cognitive, physical and lifestyle behaviours associated with the disorder. The intervention is called 'cognitive functional therapy' as it directly challenges these behaviours in a functionally specific and graduated manner.
Study NCT03115957 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Parenteral Nutrition
Description: Patients who can not tolerate 30% of target energy EN will receive supplemental parenteral nutrition at day 3 or at day 8 after abdominal surgery.
Study NCT02224586 — intervention group
Intervention type: DEVICE
Intervention: light treatment
Description: clinical routine treatment according to the doctor's advice
Study NCT04099758 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness of the breath meditation
Description: A 10-minute mindfulness of the breath meditation practice
Study NCT04099758 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Audio-recording control
Description: 10 minute non-fiction audio-recording delivered online
Study NCT03746795 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Spirometric examinations realized using the EIT
Description: Spirometric examinations will be realized using the EIT alone.